Valuation: Alcon Inc.

Market Cap 30.29B 27.01B 25.18B 22.89B 43.08B 2,931B 43.52B 302B 118B 1,494B 114B 111B 4,782B P/E 2026 *
36.2x
P/E 2027 * 22.3x
Enterprise Value 32.86B 29.31B 27.32B 24.84B 46.74B 3,181B 47.22B 328B 128B 1,621B 123B 121B 5,188B EV / Sales 2026 *
2.96x
EV / Sales 2027 * 2.7x
Free-Float
97.34%
Yield 2026 *
0.59%
Yield 2027 * 0.66%
1 day-0.95%
1 week-3.30%
Current month-3.30%
1 month-8.36%
3 months-3.76%
6 months-12.00%
Current year-17.51%
1 week 51.76
Extreme 51.76
53.74
1 month 51.76
Extreme 51.76
56.02
Current year 47.8
Extreme 47.8
68.34
1 year 47.8
Extreme 47.8
68.34
3 years 47.8
Extreme 47.8
87
5 years 47.8
Extreme 47.8
87
10 years 38.62
Extreme 38.625
87
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
7/5/26 Buy 3,000 0.0006%
27/2/26 Sell 15,000 0.0030%
27/2/26 Sell 2,412 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%-3.30%-13.86%-24.19% 30.56B
-0.24%-0.34%-25.96%+1.66% 171B
+2.62%+1.69%-10.76%+15.28% 109B
+0.57%+0.57%-24.99%+4.18% 106B
-2.49%-1.79%-48.26%-12.84% 75.43B
+1.29%+7.03%+4.09%+74.79% 60.54B
-0.44%+6.13%+10.95%+67.50% 53.16B
+1.44%+2.09%-5.08%-30.36% 49.07B
+1.28%-1.73%-18.20%+15.06% 39.92B
+0.13%-2.18%+27.84%+1.43% 31.81B
Average +0.32%+0.50%-10.42%+11.25% 72.64B
Weighted average by Cap. +0.37%+0.55%-15.94%+10.96%

Financials

2026 *2027 *
Net sales 11.09B 9.89B 9.22B 8.38B 15.78B 1,073B 15.94B 111B 43.28B 547B 41.63B 40.74B 1,751B 11.77B 10.49B 9.78B 8.89B 16.73B 1,139B 16.9B 117B 45.91B 580B 44.16B 43.21B 1,857B
Net income 792M 707M 659M 599M 1.13B 76.68B 1.14B 7.9B 3.09B 39.08B 2.97B 2.91B 125B 1.33B 1.19B 1.11B 1.01B 1.89B 129B 1.91B 13.28B 5.2B 65.72B 5B 4.89B 210B
Net Debt 2.57B 2.3B 2.14B 1.95B 3.66B 249B 3.7B 25.67B 10.05B 127B 9.66B 9.46B 407B 1.48B 1.32B 1.23B 1.12B 2.11B 144B 2.13B 14.8B 5.79B 73.22B 5.57B 5.45B 234B
Projected Income Statement - Annual - Alcon Inc.
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Date Price Change Volume
08/10/26 CHF 52.20 -0.95% 1,076,078
07/10/26 CHF 52.70 +0.04% 747,154
06/10/26 CHF 52.68 -0.75% 877,385
05/10/26 CHF 53.08 +0.45% 612,879
02/10/26 CHF 52.84 -0.04% 815,827
Trader
Investor
Global
Quality
ESG MSCI
AAA
Ratings Surperformance© - Alcon Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
62.66USD
Average target price
90.86USD
Spread / Average Target
+45.01%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Alcon Inc.